These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3188303)

  • 1. Treatment of metastatic prostate cancer. Factors that influence treatment selection and methods to increase acceptance of orchiectomy.
    Merrill DC
    Urology; 1988 Nov; 32(5):408-12. PubMed ID: 3188303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The time for serum testosterone to reach castrate level after bilateral orchiectomy or oral estrogen in the management of metastatic prostatic cancer.
    Lin BJ; Chen KK; Chen MT; Chang LS
    Urology; 1994 Jun; 43(6):834-7. PubMed ID: 8197647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma testosterone in patients receiving diethylstilbestrol.
    Beck PH; McAnich JW; Goebel JL; Stutzman RE
    Urology; 1978 Feb; 11(2):157-60. PubMed ID: 628992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of castration versus intravenous estrogen therapy in producing rapid endocrine control of metastatic cancer of the prostate.
    Maatman TJ; Gupta MK; Montie JE
    J Urol; 1985 Apr; 133(4):620-1. PubMed ID: 3981712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to gonadotropin-releasing hormone agonist in a patient with metastatic prostate cancer.
    Krongrad A; Brady J; Rodriguez RJ
    South Med J; 1997 Apr; 90(4):460-1. PubMed ID: 9114847
    [No Abstract]   [Full Text] [Related]  

  • 7. Bilateral orchiectomy for carcinoma of prostate. Response of serum testosterone and clinical response to subsequent estrogen therapy.
    Klugo RC; Farah RN; Cerny JC
    Urology; 1981 Jan; 17(1):49-50. PubMed ID: 7456197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen.
    Akakura K; Bruchovsky N; Goldenberg SL; Rennie PS; Buckley AR; Sullivan LD
    Cancer; 1993 May; 71(9):2782-90. PubMed ID: 7682149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcapsular orchiectomy with intracapsular testicular prosthesis for metastatic prostate carcinoma.
    Short KL; Howerton LW; Holt H; Amin M
    Urology; 1984 Jul; 24(1):38-40. PubMed ID: 6740847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid drop in serum testosterone after bilateral subcapsular orchiectomy.
    Arcadi JA
    J Surg Oncol; 1992 Jan; 49(1):35-8. PubMed ID: 1548879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous tunica vaginalis and subcapsular orchiectomy: a hormonal therapy for prostate cancer.
    Vickers MA; Lamontagne DP; Guru KA; Satyanarayana RK; Vickers KE; Menon M
    J Androl; 2004; 25(3):375-81. PubMed ID: 15064315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of subcapsular and total orchiectomy for treatment of metastatic prostate cancer.
    Zhang XZ; Donovan MP; Williams BT; Mohler JL
    Urology; 1996 Mar; 47(3):402-4. PubMed ID: 8633409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconsideration of orchiectomy in the treatment of advanced prostatic carcinoma.
    Jordan WP; Blackard CE; Byar DP
    South Med J; 1977 Dec; 70(12):1411-3. PubMed ID: 594790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies of subcapsular orchiectomy with an intracapsular testicular prosthesis--improving the quality of life in patients with prostatic cancer].
    Sakamoto M; Ikeuchi T; Kai Y
    Gan No Rinsho; 1989 Sep; 35(10):1143-8. PubMed ID: 2506386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting FSH in androgen-independent prostate cancer: abarelix for prostate cancer progressing after orchiectomy.
    Beer TM; Garzotto M; Eilers KM; Lemmon D; Wersinger EM
    Urology; 2004 Feb; 63(2):342-7. PubMed ID: 14972486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of action of estrogen in castration-resistant prostate cancer: clues from hormone levels.
    Aggarwal R; Weinberg V; Small EJ; Oh W; Rushakoff R; Ryan CJ
    Clin Genitourin Cancer; 2009 Oct; 7(3):E71-6. PubMed ID: 19815485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Koontz WW; Prout GR
    Invest Urol; 1972 Mar; 9(5):423-5. PubMed ID: 5016026
    [No Abstract]   [Full Text] [Related]  

  • 18. Luteinizing Hormone-Releasing Hormone Agonists are Superior to Subcapsular Orchiectomy in Lowering Testosterone Levels of Men with Prostate Cancer: Results from a Randomized Clinical Trial.
    Østergren PB; Kistorp C; Fode M; Henderson J; Bennedbæk FN; Faber J; Sønksen J
    J Urol; 2017 Jun; 197(6):1441-1447. PubMed ID: 27939836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate.
    Smith JA; Glode LM; Wettlaufer JN; Stein BS; Glass AG; Max DT; Anbar D; Jagst CL; Murphy GP
    Urology; 1985 Feb; 25(2):106-14. PubMed ID: 3918369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
    Eisenberger MA; Blumenstein BA; Crawford ED; Miller G; McLeod DG; Loehrer PJ; Wilding G; Sears K; Culkin DJ; Thompson IM; Bueschen AJ; Lowe BA
    N Engl J Med; 1998 Oct; 339(15):1036-42. PubMed ID: 9761805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.